United States decertifies Colombia as drug control partner for first time in decades

---

Full Story

For the first time in decades, the United States has decertified Colombia as a partner in combating narcotics trafficking. The decision represents a symbolic setback in relations with one of Washington’s closest allies in Latin America.

Colombia has historically been a central partner in U.S. drug control policy. Programs dating back to the 1990s focused on eradication, interdiction, and strengthening law enforcement capacity.

MEDIA REPORTING

See how news sources on all sides are covering this story.

Left 38% | Right 24% | Center 31% | Unrated 7%

The Context

Decertification does not impose automatic sanctions but signals disapproval of a country’s cooperation. Such measures have often been used by the U.S. to encourage governments to adjust policy approaches.

Colombia remains one of the world’s largest producers of coca, the raw material used to make c-caine. The crop has persisted despite decades of eradication campaigns and security assistance.

Supporters of the decertification view it as necessary to pressure Colombia into stronger anti-drug efforts. They argue that leniency risks perpetuating high levels of drug production and trafficking.

Others believe the move could undermine cooperation with a trusted ally. They stress that Colombia has borne heavy social and economic costs in pursuing drug eradication programs.

The United States has faced criticism for focusing heavily on supply-side enforcement. Advocates for reform argue that reducing domestic demand is equally important in addressing the drug trade.

This shift marks a rare public rift between the two nations. Analysts suggest it may complicate wider collaboration on security and trade issues.